Diabetes mellitus: The leading cause of haemodialysis in Jordan

Eastern Mediterranean Health Journal

Volumn 13, Issue 4, 2007, Pages 803-809

  Abdallah, S ^a   Ahmad, A T ^a   Batieha, A ^a   Ajlouni, K ^a  

^a National Center for Diabetes Endocrinology and Genetics Jordan   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FAMILY HISTORY; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFANT; INTERVIEW; JORDAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE UROPATHY; SURVIVAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CAUSALITY; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULONEPHRITIS; HUMANS; HYPERTENSION; JORDAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; RENAL DIALYSIS; SEX DISTRIBUTION;

EID: 34848893270     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Stengel B et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrology, dialysis, transplantation, 2003, 18:1824-33.
2. Usami T et al. Regional variations in the incidence of end-stage renal failure in Japan. Journal of the American Medical Association, 2000, 284:2622-4.
3. Disney AP. Some trends in chronic renal replacement therapy in Australia and New Zealand, 1997. Nephrology, dialysis, transplantation, 1998, 13:854-859.
4. US Renal Data System. USRDS 2001 annual data report: incidence of reported ESRD. Bethesda, Maryland, National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
5. Sultan A. Haemodialysis in Jordan [MSc thesis]. Amman, Jordan University of Science and Technology, 1998.
6. Gorus FK et al. Epidemiology of type 1 and type 2 diabetes. The added value of diabetes registries for conducting clinical studies: the Belgian paradigm. Acta clinical belgica, 2004, 59(1):1-13.
7. Bonow RO, Gheorghiade M. The diabetes epidemic: a national and global crisis. American journal of medicine, 2004, 116(Suppl. 5A):2S-10S.
8. Ajlouni K, Jaddou H, Batieha A. Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors. Journal of internal medicine, 1998, 244:317-23.
9. Harris MI et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US adults. Diabetes care, 1998, 21(4):518-24.
10. Simmons D, Williams DRR, Powell MJ. The Coventry Diabetes Study: prevalence of diabetes and impaired glucose tolerance in Europids and Asians. Quarterly journal of medicine, new series, 1991, 81:1021-30.
11. Reikes ST. Trends in end-stage renal disease. Postgraduate medicine, 2000, 108(1):124-6.
12. Konner K. Increasing the proportion of diabetics with AV fistulas. Seminars in dialysis, 2001, 14(1):1-4.
13. Ritz E et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. American journal of kidney diseases, 1999, 34(5):795-808.
14. Stein G, Funfstuck, Schel R. Diabetes mellitus and dialysis. Minerva urologica e nefrologrica, 2004, 56(3):289-303.
15. Al Arrayed S. Renal replacement therapy in Bahrain. Saudi journal of kidney diseases and transplantation, 1998, 9(4):457-8.
16. Al-Marhubi H. Renal replacement therapy in Sultanate of Oman. Saudi journal of kidney diseases and transplantation, 1998; 9(4):459-60.
17. Alkhunaizi AM et al. Experience in a general hospital in Eastern Saudi Arabia. Saudi medical journal, 2003, 24(7):798-800.
18. Rychlik I, Sulkova S. Diabetes mellitus a chronicka renalni insuficience. [Diabetes mellitus and chronic renal insufficiency.] Vnitrni lekarstvi, 2003, 49(5):395-402.
19. Rabkin R. Diabetic nephropathy. Clinical cornerstone, 2003; 5(2):1-11.
20. UK Prospective Diabetes Study Group. Intensive blood control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352:837-53.
21. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKRDS 38. British medical journal, 1998, 317:703-13.
22. Takruri HR, Hamzeh YS, Sweiss A. Hemodialysis patients in Jordan: a comprehensive survey. Archives of dialysis and transplantation, 1995, 24:678-82.
23. Rodriguez JA et al. Diabetic patients on renal replacement therapy: analysis of Catalan registry data. Nephrology, dialysis, transplantation, 1997, 12:2501-9.
24. UK Prospective Diabetes Study. IV. Characteristics of newly presenting type 2 diabetic patients: male preponderance and obesity at different ages: multi center study. Diabetic medicine, 1998, 5:154-9.
25. Abdella N et al. Known type II diabetes mellitus among the Kuwaiti population. A prevalence survey. Acta diabetologica, 1996, 16:145-9.
26. Guerrero RJF, Rodriguez MM, Sandoval HF. Prevalencia de diabetes mellitus no insulinodependiente en la población rural de Durango, México [The prevalence of non-insulin-dependent diabetes in the rural population of Durango, Mexico]. Revista panamericana de salud pública, 1997, 2:386-91.